Adaptive and Collaborators to Present More than 30 Abstracts at 2023 ASH Annual Meeting

Read More

Sequential T-Cell Engagement for Myeloma (STEM) Trial: A Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy